CARPAGNANO, GIOVANNA ELISIANA
 Distribuzione geografica
Continente #
NA - Nord America 5.528
EU - Europa 1.964
AS - Asia 1.663
SA - Sud America 584
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.779
Nazione #
US - Stati Uniti d'America 5.447
SG - Singapore 606
BR - Brasile 537
HK - Hong Kong 497
RU - Federazione Russa 448
SE - Svezia 427
CN - Cina 300
IT - Italia 254
DE - Germania 253
GB - Regno Unito 138
FR - Francia 115
FI - Finlandia 95
UA - Ucraina 68
IN - India 60
CA - Canada 50
VN - Vietnam 47
ID - Indonesia 37
NL - Olanda 28
CZ - Repubblica Ceca 27
BD - Bangladesh 26
AT - Austria 24
IE - Irlanda 20
PL - Polonia 19
BE - Belgio 16
LT - Lituania 16
MX - Messico 16
TR - Turchia 16
ZA - Sudafrica 13
SA - Arabia Saudita 12
AR - Argentina 11
IQ - Iraq 11
ES - Italia 10
CO - Colombia 8
MA - Marocco 8
UZ - Uzbekistan 8
VE - Venezuela 8
PK - Pakistan 7
PY - Paraguay 7
EG - Egitto 6
EC - Ecuador 5
JP - Giappone 5
JM - Giamaica 4
BO - Bolivia 3
KE - Kenya 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
SC - Seychelles 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CL - Cile 2
DK - Danimarca 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
OM - Oman 2
TN - Tunisia 2
UY - Uruguay 2
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 9.779
Città #
Fairfield 787
Chandler 534
Hong Kong 493
Ashburn 451
Singapore 451
Woodbridge 439
Nyköping 354
Seattle 331
Houston 298
Cambridge 287
Wilmington 253
Jacksonville 143
Lawrence 142
Roxbury 126
Ann Arbor 120
Munich 107
New York 96
Des Moines 92
Inglewood 62
San Diego 58
Los Angeles 57
Helsinki 50
London 50
Paris 47
Bari 43
São Paulo 42
Dearborn 37
Jakarta 37
Beijing 35
Nanjing 35
Frankfurt am Main 33
Santa Clara 33
Princeton 32
Brooklyn 31
Boardman 29
Dong Ket 29
Rome 29
Nuremberg 22
Guangzhou 21
Milan 20
Rio de Janeiro 19
Chicago 18
Toronto 18
Dublin 17
Brussels 16
Falkenstein 16
Belo Horizonte 14
Brasília 14
Olomouc 14
Turku 14
Warsaw 14
Moscow 13
San Francisco 13
Columbus 12
Hebei 12
Washington 12
Brno 11
Norwalk 11
Pune 11
Shanghai 11
Shenyang 11
Xi'an 11
Montreal 10
Turi 10
Ottawa 9
Porto Alegre 8
The Dalles 8
Tianjin 8
Vienna 8
Atlanta 7
Fortaleza 7
Siena 7
Tashkent 7
Amsterdam 6
Auburn Hills 6
Changsha 6
Charlotte 6
Chennai 6
Dhaka 6
Hanoi 6
Hounslow 6
Istanbul 6
Jiaxing 6
Leipzig 6
Ribeirão Preto 6
Riyadh 6
Roubaix 6
Stockholm 6
Taranto 6
Wuhan 6
Buffalo 5
Caxias do Sul 5
Curitiba 5
Düsseldorf 5
Falls Church 5
Grottaglie 5
Ho Chi Minh City 5
Hyderabad 5
Jeddah 5
Johannesburg 5
Totale 6.879
Nome #
Application of machine learning to predict obstructive sleep apnea syndrome severity 157
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica" 149
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 139
Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine 132
Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma 125
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 121
Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. 113
Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA) 112
3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer 111
8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy 104
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients 102
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys) 102
Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. 98
Exhaled inflammatory markers in aspirin-induced asthma syndrome. 98
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease 97
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation 95
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 95
Predictive equations for CPAP titration in OSAS patients 94
Menopausal asthma: a new biological phenotype? 89
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 89
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 88
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 86
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 83
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 82
The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate 80
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 79
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 77
A European respiratory society technical standard: Exhaled biomarkers in lung disease 76
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 76
Airway inflammation in patients affected by obstructive sleep apnea syndrome 75
Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma 74
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 74
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 73
Aging and airway inflammation 73
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer 70
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 70
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational Study 68
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 68
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 68
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 68
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome 67
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma 67
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 67
Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome 66
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 66
Analysis of mitochondrial DNA alteration in new phenotype ACOS 66
Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge 64
Omalizumab as add-on therapy in a patient with severe asthma and OSA 64
Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate 64
IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients 63
Evidence of lower oxidative stress in the air spaces of patients with reversible COPD 63
Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation? 63
Diurnal PaCO2 tension in obese women: relationship with sleep disordered breathing 62
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 62
Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy 62
Microparticles in sputum of COPD patients: a potential biomarker of the disease? 62
Association between exhaled nitric oxide and nasal polyposis in severe asthma 61
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 61
The association between dysphagia and OSA Disfagia e OSA 61
Systemic and airways inflammation in healthy subjects of different ages 59
Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide 59
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 58
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects 57
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 56
MicroRNA expression profile during different conditions of hypoxia 56
Exhaled matrix metalloproteinase-9 in lung cancer 56
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 56
Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension 55
Characterization of obstructive sleep apnea–hypopnea syndrome (OSA) population by means of cluster analysis 55
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 55
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 55
Mitochondrial DNA alteration in obstructive sleep apnea 54
Values in Elderly People for Exhaled Nitric Oxide Study 54
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax 54
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 53
Airways oxidative stress, lung function and cognitive impairment in aging 53
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 53
How strong is the association between IPF and lung cancer? An answer from airway’s DNA 53
Wake-up call by breathomics in sleep apnoea 53
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 52
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: How hot is the link? 52
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 52
Systemic and airways inflammation in healthy subjects and COPD patients of different ages 51
VIP: A New Promising Marker for AECOPD-A Fashionable Marker Soon Forgotten? 51
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients 51
HPV in exhaled breath condensate of lung cancer patients 51
Dyspnea perception in asthma: Role of airways inflammation, age and emotional status 51
Exhaled breath temperature in NSCLC: Could be a new non-invasive marker? 51
Coexistent Sarcoidosis and Tuberculosis: A Case Report 51
Breathing rhythm variations during wash-in do not influence exhaled volatile organic compound profile analyzed by an electronic nose 51
HPV-associated lung cancers: An international pooled analysis 50
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? 50
Effects of omalizumab in severe asthmatics across ages: A real life Italian experience 50
Correlation between nasal inflammation assessed by nasal cytology and blood neutrophil-to-lymphocyte ratio in patients with copd 49
Airway cell patterns in patients suffering from COPD and OSAS (Overlap Syndrome) 49
Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients 49
Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV 48
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma? 48
Microsatellite alterations and cell-free dna analysis: Could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion? 47
Validation of the Exhaled Breath Temperature Measure: Reference Values in Healthy Subjects 47
Totale 7.096
Categoria #
all - tutte 64.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.662 206 41 223 72 139 26 345 113 166 110 155 66
2021/2022947 58 43 3 23 41 115 50 49 110 53 185 217
2022/20231.477 189 211 96 86 145 218 41 153 246 11 49 32
2023/2024708 45 125 52 55 93 172 23 25 17 19 9 73
2024/20253.528 117 59 198 115 110 369 320 340 133 203 509 1.055
2025/2026357 357 0 0 0 0 0 0 0 0 0 0 0
Totale 10.273